Page 12 - Curis Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Curis inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Curis Inc Today - Breaking & Trending Today
Gainers Vistagen Therapeutics, Inc. (NASDAQ: VTGN) shares jumped 747.6% to $14.24 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of fasedienol met the primary and secondary endpoints. ....
Curis (NASDAQ:CRIS – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at HC Wainwright in a report issued on Friday, Benzinga reports. They currently have a $6.00 price target on the biotechnology company’s stock. Separately, StockNews.com cut shares of Curis from a “buy” rating to a “hold” rating in a research note […] ....
Curis, Inc. (NASDAQ:CRIS – Get Free Report) saw a large drop in short interest in July. As of July 15th, there was short interest totalling 1,580,000 shares, a drop of 8.1% from the June 30th total of 1,720,000 shares. Based on an average trading volume of 298,100 shares, the days-to-cover ratio is currently 5.3 days. […] ....
Removal of partial clinical hold – enrolling patients at confirmed RP2D in the TakeAim Leukemia Study Enrolling patients in the TakeAim Lymphoma Study in combination with ibrutinib Strong balance. ....